EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Assessing Novel Antibody‐Based Therapies in Reconstructive 3D Cell Models of the Tumor Microenvironment

Giacomo Domenici iD, Nuno F Lopes iD, Gonçalo Trindade iD, Isabella Ramella Gal iD, Joan Miret Minard iD, Sofia P Rebelo iD, Catarina Freitas iD, Nádia Duarte iD, Catarina Brito iD

Advanced Biology · 2024

DOI: 10.1002/adbi.202400431 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Biology, 2024. Verfasst von Giacomo Domenici und 8 weiteren Autor:innen. Beteiligte Einrichtung: iBET, Instituto de Biologia Experimental e Tecnológica, Apartado 12, Oeiras, 2780-901, Portugal. Hauptthemen laut MEDLINE: Tumor Microenvironment, Breast Neoplasms, Immunoconjugates. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 95 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Fundação para a Ciência e a Tecnologia/ Ministério da Ciência, Tecnologia e Ensino Superior, Ministério da Ciência, Tecnologia e Ensino Superior, Associate Laboratory LS4FUTURE.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Targeted, combinatorial, and immunomodulatory therapies, such as antibody‐drug conjugates (ADCs) and immunomodulatory antibodies (Abs), are powerful weapons against tumor cells and immune cells within the tumor microenvironment (TME). Therefore, the evaluation of such therapies should be conducted in pre‐clinical models able to recapitulate the complex cellular and molecular crosstalk of the TME. To build‐in critical hallmarks of the TME, a breast cancer heterotypic 3D cell model (3D‐3) is devised using a microencapsulation strategy with an inert biomaterial (alginate) and agitation‐based cultures. Both stromal and immune components are added to multicellular tumor spheroids, therefore fostering cancer‐associated fibroblasts (CAFs) and tumor‐associated macrophages (TAMs) immunomodulatory interactions. The potential of the methodology to assess Ab‐based therapies is then addressed by employing a series of anti‐HER2‐based ADCs. ADCs induced tumor‐cell specific cytotoxicity toward HER2+ breast cancer spheroids while sparing HER2‐negative CAFs. In addition, an immunomodulatory blocking Ab against colony‐stimulating factor 1 receptor (CSF1R) decreases the expression of immunosuppressive and anti‐inflammatory markers in TAMs, like what is previously observed upon in vivo α‐CSF1R administration. Collectively, the human TME‐based 3D‐3 cell model is a suitable tool to evaluate the anti‐tumor and immunomodulatory potential of novel antibody‐based therapies directed against TME targets, such as cancer cells and macrophages.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Tumor MicroenvironmentBreast NeoplasmsImmunoconjugatesHumansSpheroids, CellularFemaleCell Line, TumorTumor-Associated MacrophagesCancer-Associated FibroblastsErb-b2 Receptor Tyrosine Kinases

Stichwörter der Autor:innen

3D cancer modelsantibody‐drug conjugatescancer‐associated fibroblaststargeted therapiestumor‐associated macrophages

Substanzen

ImmunoconjugatesErb-b2 Receptor Tyrosine Kinases

Autor:innen und Institutionen

  • iBET, Instituto de Biologia Experimental e Tecnológica, Apartado 12, Oeiras, 2780-901, Portugal.
  • Instituto de Tecnologia Química e Biológica António Xavier, Universidade Nova de Lisboa, Av. da República, Oeiras, 2780-157, Portugal.
  • Department of Chemical, Biological and Environmental Engineering, Universitat Autònoma de Barcelona, Plaça Cívica, Bellaterra, 08193, Spain.

ORCID-Profile: Giacomo Domenici, Nuno F Lopes, Gonçalo Trindade, Isabella Ramella Gal, Joan Miret Minard, Sofia P Rebelo, Catarina Freitas, Nádia Duarte, Catarina Brito

Förderung

  • Fundação para a Ciência e a Tecnologia/ Ministério da Ciência, Tecnologia e Ensino Superior
  • Ministério da Ciência, Tecnologia e Ensino Superior
  • Associate Laboratory LS4FUTURE

Zitieren

APA

Domenici, G., Lopes, N. F., Trindade, G., Ramella Gal, I., Miret Minard, J., Rebelo, S. P., Freitas, C., Duarte, N., & Brito, C. (2024). Assessing Novel Antibody‐Based Therapies in Reconstructive 3D Cell Models of the Tumor Microenvironment. Advanced Biology. https://doi.org/10.1002/adbi.202400431

Vancouver

Domenici G, Lopes NF, Trindade G, Ramella Gal I, Miret Minard J, Rebelo SP, et al. Assessing Novel Antibody‐Based Therapies in Reconstructive 3D Cell Models of the Tumor Microenvironment. Advanced Biology. 2024. doi:10.1002/adbi.202400431

BibTeX
@article{Domenici2024,
  author = {Domenici, Giacomo and Lopes, Nuno F and Trindade, Gonçalo and Ramella Gal, Isabella and Miret Minard, Joan and Rebelo, Sofia P and Freitas, Catarina and Duarte, Nádia and Brito, Catarina},
  title = {Assessing Novel Antibody‐Based Therapies in Reconstructive 3D Cell Models of the Tumor Microenvironment},
  journal = {Advanced Biology},
  year = {2024},
  doi = {10.1002/adbi.202400431}
}
Kostenlos starten →